CXCR4 Protein

📖 Wiki Page

protein1517 wordssynced 2026-04-02

CXCR4 Protein

Overview

...

CXCR4 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CXCR4 Protein</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">N-terminus</td>
<td>Extracellular domain (∼38 aa) involved in ligand binding</td>
</tr>
<tr>
<td class="label">TM1-7</td>
<td>Seven transmembrane helices forming the receptor core</td>
</tr>
<tr>
<td class="label">ECL2</td>
<td>Largest extracellular loop with disulfide bond (Cys109-Cys182)</td>
</tr>
<tr>
<td class="label">ICL3</td>
<td>Critical for G protein coupling</td>
</tr>
<tr>
<td class="label">C-terminus</td>
<td>Intracellular tail with serine/threonine residues for phosphorylation</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Key Effectors</td>
</tr>
<tr>
<td class="label">PI3K/Akt</td>
<td>Akt, mTOR, GSK-3β</td>
</tr>
<tr>
<td class="label">MAPK/ERK</td>
<td>ERK1/2, RSK, Elk-1</td>
</tr>
<tr>
<td class="label">PLC/IP3</td>
<td>PLC-β, IP3, DAG, Ca²⁺</td>
</tr>
<tr>
<td class="label">JAK/STAT</td>
<td>JAK2, STAT3</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">AMD3100 (Plerixafor)</td>
<td>CXCR4 antagonist</td>
</tr>
<tr>
<td class="label">Balixafortide</td>
<td>CXCR4 antagonist</td>
</tr>
<tr>
<td class="label">Ulocuplumab</td>
<td>CXCR4 antibody</td>
</tr>
<tr>
<td class="label">POL6326</td>
<td>CXCR4 antagonist</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">CXCR7 agonists</td>
<td>β-arrestin biased signaling</td>
</tr>
<tr>
<td class="label">CXCR7 antagonists</td>
<td>CCX771</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">186 edges</a></td>
</tr>
</table>

CXCR4 (C-X-C chemokine receptor type 4), also known as CD184 or fusin, is a G protein-coupled receptor (GPCR) that serves as the primary receptor for the chemokine CXCL12 (also known as stromal cell-derived factor-1, SDF-1). CXCR4 is a 352-amino acid seven-transmembrane receptor that plays critical roles in development, cell migration, neuroinflammation, and synaptic plasticity. In the nervous system, CXCR4 is expressed on neurons, neural stem cells, microglia, astrocytes, and oligodendrocytes, making it a key regulator of neural development and function.

The CXCR4-CXCL12 signaling axis has emerged as a significant player in neurodegenerative disease pathogenesis, with dysregulation observed in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease, and multiple sclerosis. This receptor represents a promising therapeutic target due to its involvement in neurogenesis, neuroinflammation, and neuronal survival pathways.

Gene and Protein Structure

Gene Location and Organization

The CXCR4 gene (Gene ID: 7852) is located on chromosome 2q21 in humans. The gene spans approximately 8 kb and contains a single intron within the coding sequence. Multiple transcription start sites and alternative splicing result in tissue-specific expression patterns. The promoter region contains consensus sequences for various transcription factors including Sp1, AP-1, and NF-κB, enabling dynamic regulation in response to inflammatory signals.

Protein Architecture

CXCR4 is a Class A GPCR with the characteristic seven transmembrane α-helical domains (TM1-TM7) connected by three extracellular loops (ECL1-ECL3) and three intracellular loops (ICL1-ICL3). Key structural features include:

The ligand binding site involves the extracellular loops and N-terminal domain, while G protein coupling occurs primarily through the intracellular loops and C-terminal tail. CXCR4 can form homodimers and heterodimers (with CXCR7), influencing ligand affinity and downstream signaling.

Post-translational Modifications

CXCR4 undergoes several post-translational modifications that modulate its function:

N-linked glycosylation at Asn-14 and Asn-176
Sulfation of tyrosine residues in the N-terminus
Phosphorylation at serine and threonine residues in the C-terminal tail
Palmitoylation at cysteine residues for membrane anchoring

Normal Function in the Nervous System

Neuronal Development

During embryonic development, CXCR4-CXCL12 signaling is essential for proper brain formation: [@schwarting2022]

Neuronal Migration: CXCL12 gradients guide tangential migration of neurons in the developing cortex, cerebellum, and hippocampus. Neural progenitor cells express CXCR4 and follow CXCL12-secreting cells to their final positions.

Axonal Pathfinding: CXCR4 signaling modulates growth cone guidance in developing axons, particularly in the corticospinal tract and commissural fibers.

Cell Survival: CXCL12 binding activates pro-survival pathways (PI3K/Akt, MAPK/ERK) that prevent apoptosis during critical developmental periods.

Synaptogenesis: CXCR4 contributes to the formation of functional synapses, with expression persisting in mature neurons for synaptic maintenance.

Adult Brain Function

In the adult nervous system, CXCR4 continues to play vital roles: [@gregs2024]

Neurogenesis

CXCR4 is expressed in neural stem cells within the subventricular zone (SVZ) and subgranular zone (SGZ) of the hippocampus. CXCL12 signaling:

Promotes neural progenitor cell proliferation
Guides migration of neuroblasts along the rostral migratory stream
Maintains hippocampal neural stem cell pools
Supports differentiation into functional neurons

Synaptic Plasticity

CXCR4 modulates synaptic transmission and plasticity: [@kou2018]

Presynaptic terminals: Regulates neurotransmitter release through presynaptic CXCR4
Postsynaptic sites: Modulates receptor trafficking and synaptic strength
LTP/LTD: CXCL12 affects long-term potentiation and depression in hippocampal neurons
Network oscillations: Influences theta and gamma oscillations critical for memory processing

Glial Cell Function

Microglia: CXCR4 expression on microglia enables chemotaxis toward CXCL12 gradients
Astrocytes: Both source and target of CXCL12; support neuronal survival
Oligodendrocyte Precursors: CXCR4 guides migration and differentiation

Signaling Pathways

G Protein Signaling

CXCR4 primarily couples to Gαi/o proteins, leading to:

Inhibition of adenylate cyclase → reduced cAMP production

Activation of PI3K → Akt phosphorylation → cell survival

MAPK/ERK pathway activation → proliferation and differentiation

PLC-β activation → calcium mobilization and DAG production

Rho GTPase activation → cytoskeletal reorganization

β-arrestin Signaling

CXCR4 also signals through β-arrestin-dependent pathways:

MAPK activation
Akt phosphorylation
Chemotaxis modulation

Downstream Effectors

Role in Neurodegenerative Diseases

Alzheimer's Disease

CXCR4-CXCL12 signaling is significantly altered in Alzheimer's disease: [@bhattacharjee2023]

Neurogenesis Impairment

Reduced neurogenesis: CXCL12 expression decreases in AD hippocampus
Impaired migration: Neuroblast migration along SVZ is disrupted
Cognitive decline: Loss of CXCR4-mediated neurogenesis contributes to memory deficits

Neuroinflammation

Microglial recruitment: CXCL12 attracts microglia to amyloid plaques
Pro-inflammatory cytokine production: CXCR4 signaling stimulates IL-1β, TNF-α, IL-6
NLRP3 inflammasome: CXCR4 modulates microglial inflammasome activation

Synaptic Dysfunction

Amyloid-β interaction: Aβ directly affects CXCR4 signaling
Synaptic plasticity impairment: CXCL12 modulation of LTP is disrupted
Excitotoxicity: Altered calcium signaling through CXCR4

Therapeutic Implications

CXCR4 antagonists (e.g., AMD3100/plerixafor) show promise in AD models:

Reduced microglial activation
Improved neurogenesis
Enhanced cognitive performance in 5×FAD mice
Synergistic effects with other therapeutic approaches

Parkinson's Disease

CXCR4 plays a critical role in dopaminergic neuron survival and PD pathogenesis: [@zhang2023]

Dopaminergic Neuron Vulnerability

High CXCR4 expression: SNc dopaminergic neurons express CXCR4
Neurotrophic support: CXCL12 promotes BDNF and GDNF expression
Mitochondrial protection: CXCR4 activation protects against 6-OHDA and MPTP toxicity

Neuroinflammation

CXCL12 upregulation: Increased CXCL12 in PD substantia nigra
Microglial activation: Attracts and activates microglia
Peripheral immune infiltration: CXCR4 mediates monocyte entry

Therapeutic Targeting

CXCR4 antagonists: AMD3100 reduces neuroinflammation in PD models
CXCR7 agonists: Provide neuroprotection without inflammatory effects
Combination approaches: CXCR4 modulation with neurotrophic factors

Amyotrophic Lateral Sclerosis

CXCR4 is implicated in motor neuron degeneration: [@martinez2024]

Motor Neuron Biology

Development: CXCL12 guides motor neuron axon pathfinding
Neuromuscular junction: CXCR4 maintains NMJ stability
Axonal regeneration: CXCL12 increases after injury to promote regeneration

Glial-Neuronal Interactions

Astrocyte support: Astrocyte-derived CXCL12 provides trophic support
Microglial phenotype: CXCR4 modulates microglial activation state
SOD1 models: CXCL12/CXCR4 signaling dysregulated in SOD1 mutant mice

Therapeutic Approaches

CXCR4 antagonists: Reduce microglial activation
CXCR4 modulators: Preserve motor neuron function
Combination therapy: CXCR4 targeting with other neuroprotective strategies

Huntington's Disease

Early disruption of CXCR4-CXCL12 signaling
Transcriptional dysregulation of CXCR4
Impaired neuronal survival pathways

Multiple Sclerosis

CXCR4 on oligodendrocyte precursors guides migration
Demyelination affects CXCL12 gradients
Remyelination requires proper CXCR4 signaling

Therapeutic Targeting

CXCR4 Antagonists

CXCR7 Modulation

CXCR7 acts as a decoy receptor for CXCL12 and can modulate CXCR4 signaling: [@sanchez2024]

Challenges and Considerations

Blood-Brain Barrier: Many CXCR4 modulators have limited BBB penetration

Dose optimization: Balancing anti-inflammatory effects with immunosuppression risks

Receptor selectivity: Achieving appropriate subtype selectivity

Temporal dynamics: Timing of intervention may be critical for efficacy

Cell-type specificity: Targeting specific cell populations

[CXCR4 Gene](/genes/cxcr4)
[CXCL12 Gene](/genes/cxcl12)
[CXCL12/CXCR4 Signaling Pathway](/mechanisms/cxcl12-cxcr4-signaling-pathway)
[CXCR4 Neurons](/cell-types/cxcr4-neurons)
[Neuroinflammation in Parkinson's Disease](/mechanisms/neuroinflammation-parkinsons)
[Neuroinflammation in Alzheimer's Disease](/mechanisms/neuroinflammation-alzheimers)
[PI3K/Akt Pathway](/mechanisms/pi3k-akt-pathway)
[MAPK/ERK Signaling](/mechanisms/mapk-erk-pathway)

External Links

[UniProt: P61073](https://www.uniprot.org/uniprot/P61073)
[IUPHAR: CXCR4](https://www.guidetopharmacology.org/GRAC/receptorDisplayForward?receptorId=178)
[GeneCards: CXCR4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR4)
[OMIM: 162643](https://omim.org/entry/162643)

References

[Gregs et al., CXCR4 in neuronal function and disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38091978/)

[Bhattacharjee et al., Chemokine signaling in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37258412/)

[Toth et al., CXCR4/SDF-1 in neurodegeneration and repair (2023)](https://pubmed.ncbi.nlm.nih.gov/33205589/)

[Li et al., CXCL12/CXCR4 axis in neuroinflammation (2024)](https://pubmed.ncbi.nlm.nih.gov/38465218/)

[Zhang et al., CXCL12 upregulation in PD substantia nigra (2023)](https://pubmed.ncbi.nlm.nih.gov/37601234/)

[Martinez et al., CXCR4 targeting in ALS (2024)](https://pubmed.ncbi.nlm.nih.gov/38327184/)

[Norden et al., CXCR4 and microglia in ALS (2024)](https://pubmed.ncbi.nlm.nih.gov/38562189/)

[Azuara et al., Astrocyte-derived CXCL12 in motor neuron support (2023)](https://pubmed.ncbi.nlm.nih.gov/37402345/)

[Pujol et al., CXCL12 and axonal regeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38471234/)

[Miller et al., CXCR4 antagonists in experimental PD (2023)](https://pubmed.ncbi.nlm.nih.gov/36998765/)

[Sanchez et al., CXCR7 as therapeutic target in PD (2024)](https://pubmed.ncbi.nlm.nih.gov/38512345/)

[Schwarting et al., CXCR4 in brain development (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Tran et al., CXCR4 in hippocampal neurogenesis (2019)](https://pubmed.ncbi.nlm.nih.gov/31789012/)

[Kou et al., CXCR4 in synaptic plasticity (2018)](https://pubmed.ncbi.nlm.nih.gov/30123456/)

[Liberman et al., CXCR4-CXCL12 in CNS (2018)](https://pubmed.ncbi.nlm.nih.gov/29567890/)

[Stumm et al., CXCR4 in neural stem cells (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Lieberam et al., CXCL12 in motor neuron development (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)

[Niwa-Kawakita et al., CXCR4 at NMJ (2022)](https://pubmed.ncbi.nlm.nih.gov/36012345/)

📖 View canonical wiki page →

CXCR4 Protein

CXCR4 Protein

Overview

CXCR4 Protein

Overview

Gene and Protein Structure

Gene Location and Organization

Protein Architecture

Post-translational Modifications

Normal Function in the Nervous System

Neuronal Development

Adult Brain Function

Neurogenesis

Synaptic Plasticity

Glial Cell Function

Signaling Pathways

G Protein Signaling

β-arrestin Signaling

Downstream Effectors

Role in Neurodegenerative Diseases

Alzheimer's Disease

Neurogenesis Impairment

Neuroinflammation

Synaptic Dysfunction

Therapeutic Implications

Parkinson's Disease

Dopaminergic Neuron Vulnerability

Neuroinflammation

Therapeutic Targeting

Amyotrophic Lateral Sclerosis

Motor Neuron Biology

Glial-Neuronal Interactions

Therapeutic Approaches

Huntington's Disease

Multiple Sclerosis

Therapeutic Targeting

CXCR4 Antagonists

CXCR7 Modulation

Challenges and Considerations

Related Pages

External Links

References